Literature DB >> 11741995

Cloning and characterization of Scavidin, a fusion protein for the targeted delivery of biotinylated molecules.

Pauliina Lehtolainen1, Anna Taskinen, Johanna Laukkanen, Kari J Airenne, Sanna Heino, Maarit Lappalainen, Kirsi Ojala, Varpu Marjomäki, John F Martin, Markku S Kulomaa, Seppo Ylä-Herttuala.   

Abstract

We have constructed a novel fusion protein "Scavidin" consisting of the macrophage scavenger receptor class A and avidin. The Scavidin fusion protein is transported to plasma membranes where the avidin portion of the fusion protein binds biotin with high affinity and forms the basis for the targeted delivery of biotinylated molecules. Subcellular fractionation analysis, immunostaining, and electron microscopy demonstrated endosomal localization of the fusion protein. According to pulse-labeling and cross-linking studies Scavidin is found as monomers (55 kDa), dimers, and multimers, of which the 220-kDa form was the most abundant. The biotin binding capacity and active endocytosis of the biotinylated ligands were demonstrated in rat malignant glioma. Local Scavidin gene transfer to target tissues could have general utility as a universal tool to deliver biotinylated molecules at systemic low concentrations for therapeutic and imaging purposes, whereby high local concentration is achieved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741995     DOI: 10.1074/jbc.M109431200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Authors:  Giovanni Paganelli; Marco Chinol
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-30       Impact factor: 9.236

2.  Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.

Authors:  Antonio Verdoliva; Piero Bellofiore; Vincenzo Rivieccio; Sergio Catello; Maurizio Colombo; Claudio Albertoni; Antonio Rosi; Barbara Leoni; Anna Maria Anastasi; Rita De Santis
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.